595
views
0
recommends
+1 Recommend
1 collections
    1
    shares

      CVIA now indexed by SCOPUS from February 2024. CVIA received its first Journal Impact Factor (0.5) in the 2023 Journal Citation Reports Release. 

      Interested in becoming a CVIA published author?

      • Platinum Open Access with no APCs. 
      • Fast peer review/Fast publication online after article acceptance.

      Submissions should be made electronically at: https://mc04.manuscriptcentral.com/cvia-journal.

      Please refer to the Author Guidelines at https://cvia-journal.org/instructions-to-authors/ before submission.

       

      scite_
       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Surgical Management of Ebstein Anomaly

      review-article
      Bookmark

            Abstract

            Among all congenital heart disease, Ebstein anomaly is the lesion with the widest spectrum of presentation. It can present as early as the neonatal period where immediate intervention is often needed to the adult with no discernable symptoms. It is also one where overall outcome greatly relates to age at presentation. Generally, presentation in the neonatal period is associated with poor outcomes while presentation beyond the neonatal period has excellent outcomes with low operative mortality. It is thus apparent that understanding every aspect of the anatomy and physiology of Ebstein anomaly and how it manifests clinically is paramount to successful treatment. The purpose of this review is to outline the current concepts and strategies in the surgical management of Ebstein anomaly, and to discuss the current expert consensus on how best to tackle this congenital heart disease at different ages of diagnosis.

            Main article text

            Anatomy

            Ebstein anomaly comprises about 1% of all congenital heart disease. Almost all cases are sporadic, although it has been associated with maternal lithium therapy [1]. It is a malformation of the tricuspid valve (TV) and right ventricle (RV) and is characterized by: (a) failure of delamination of the septal and posterior leaflets resulting in adherence of the leaflets to the myocardium, (b) downward or apical displacement of the tricuspid annulus, (c) “atrialization” of a portion of the RV, (d) anterior leaflet “sail-like” redundancy, tethering and fenestrations; and (e) dilatation of the right atrioventricular (annular) junction [2, 3] (Figure 1).

            Figure 1:

            In Ebstein Anomaly, there is Failure Delamination of the Tricuspid Leaflet, a “Sail-Like’’ Anterior Leaflet, Downward Displaced of the Tricuspid Annulus, “Atrialization” of a Portion of the Right Ventricle, and Dilatation of the Tricuspid Annulus.

            In normal hearts, there is a downward displacement of the septal and posterior leaflets in relation to the mitral leaflet of less than 8 mm/m2 body surface area [2]. However, in Ebstein anomaly there is a wide range of displacement of the posterior and septal leaflet from mild to complete tethering or an imperforate membrane or muscular shelf between the inlet and trabecular areas of the RV. The anterior leaflet is generally described as large, redundant and “sail-like”; and may contain fenestrations. Chordae are poorly developed and short and may not completely support the anterior leaflet. Occasionally, severely deformed anterior leaflets may obstruct the right ventricular outflow tract. These abnormal pathologies all contribute to the varying degrees of severity of tricuspid regurgitation. As for the anatomic TV annulus, it is usually severely dilated. The functional RV is often not located below the anatomic TV annulus but an “atrialized” portion often separates the true TV annulus from functional RV. The distinction between the “atrialized” portion and the functional RV is made by observing the appearance of the right ventricular wall. The “atrialized” RV will have a smooth myocardium that is dyskinetic, while functional RV will have a trabeculated myocardium. Furthermore, on inspection of the surface coronary anatomy, the right coronary artery is at the level of the true TV annulus that corresponds with the true atrioventricular junction.

            In Ebstein anomaly, the RV is divided into two regions: the inlet region which is the area involved in the malformation and functionally part of the right atrium (RA), and the trabecular and outlet region which is the functional component of the RV. The severity of function of the RV is greatly dependent on the volume of the trabecular and outlet regions. In severe forms of Ebstein anomaly, the volume of the “atrialized” portion of the RV is significantly dilated and larger (more than half) than the trabecular and outlet region and this results in severely depressed RV function. In severe cases of right ventricular dilation, the dilation is not solely from the “atrialized” portion. The functional portion also becomes dilated and this is usually at the apex and outflow tract. Left ventricular function can also be severely impacted when there is severe right ventricular dilatation through compression of the left ventricular chamber and occasionally through left ventricular outflow tract obstruction [4].

            Other forms of congenital heart disease may be present along with Ebstein anomaly. Interatrial communications are most common [4], and other right-sided lesions such as pulmonary stenosis or pulmonary atresia, as well as branch pulmonary artery stenosis and patent ductus arteriosus, are also frequently seen. The most commonly associated arrhythmias are from accessory conduction pathways (Wolf Parkinson White syndrome) often seen in younger patients and atrial flutter or fibrillation which is often seen in older patients [5, 6].

            Classification Systems

            The Carpentier classification is used to classify the severity of Ebstein anomaly. In Type A there is an adequate sized RV (small degree of atrialized RV), with normal anterior leaflet, but moderate displacement of the septal/posterior leaflets; Type B there is a small functional RV and a large atrialized RV with free movement of the anterior leaflet; Type C also has a small functional RV and a large atrialized RV, but the anterior leaflet is severely restricted which may cause significant right ventricular outflow tract obstruction; and in Type D there is almost complete atrialization of the RV with a small infundibular component [7].

            In neonates, Celermajer et al. [8] described an echocardiographic grading score, the extended Glasgow Outcome Scale. It is the ratio of combined right atrium and atrialized RV to the functional RV and left heart ratio with grades between 1 and 4. It is used as an as objective criterion for mortality risk (Grade 1 is a ratio of <0.5. Grade 2 has a ratio between 0.5 and 0.99. Grade 3 has a ratio 1.0–1.49. Grade 4 has a ratio >1.5).

            Pathophysiology and Clinical Presentation

            The principal abnormality in patients with Ebstein anomaly is the decrease or lack of flow through the right side of the heart due to impaired RV contractility and tricuspid regurgitation. The impaired contractility is a result of a lack of functioning RV which progressively worsens as the right side of the heart is volume loaded and the RV progressively dilates even further, worsening contractility. The incompetence of the TV also results in dilation of both the RA and RV. The right ventricular dysfunction in the presence of an atrial level communication results in right to left shunting of blood with arterial desaturation.

            The proportion to which the right atrium and ventricle can dilate is immense. In neonates with severe Ebstein anomaly, the chest X-ray may show a so-called “wall-to-wall” heart. Worrisome in neonates is not only the severity of cardiac enlargement, but also the retarded effect on pulmonary development and function that can be caused by lack of adequate pulmonary blood flow. Beyond the neonatal and infancy period are where most diagnosis of Ebstein anomaly is made. These are infants, children and adults with varying but lesser degrees of right ventricular dysfunction and tricuspid regurgitation. They will usually present with symptoms such as exertional dyspnea, fatigue, cyanosis or palpitations. Others, especially children greater than 10 years and adults may present with arrhythmias [8]. However, many remain completely asymptomatic and are incidentally found. Rarely, adults will present with another medical condition such as paradoxical embolization from right to left shunting of an interatrial communication as their initial presenting symptom [9].

            Given the varying presentations, there are no specific physical examination findings pathognomonic for Ebstein anomaly. Cyanosis may be present especially in symptomatic neonates or none at all in the asymptomatic child or adult. Signs of right sided heart failure such as jugular venous distention and hepatic congestion may be present in advanced cases, or none at all when the RA and RV is highly compliant. Regurgitation murmurs are usually soft if present due to large coaptation gaps, low right ventricular pressures and low velocity flows across the tricuspid valve and right ventricular outflow tract. Given all of the above, a patient may walk in completely asymptomatic and all that is found is a split-second heart sound from conduction delay and this will be the only physical finding that will point to a severe form of congenital heart disease; thus vigilance and a low threshold should be present for additional diagnostic testing in the presence of any suspicious findings.

            Diagnosis

            Two-dimensional echocardiography is the diagnostic test of choice for Ebstein anomaly. Principal features are: (a) apical displacement of the septal leaflet from the insertion of the mitral leaflet by at least 8 mm/m2 body surface area [2], and (b) failure of delamination with points of tethering between leaflets and underlying myocardium causing restriction of motion [10] (Figure 2). In the recent era, 3D echocardiography has become an important adjunct in analysis of the TV leaflets and subvalvar apparatus. This has been particularly important for pre-operative planning of valve reconstruction.

            Figure 2:

            Two-Dimensional Echocardiographic Image of a Patient with Ebstein Anomaly.

            Principal features are apical displacement of the septal leaflet by at least 8 mm/m2 body surface area and failure of delamination with points of tethering between leaflets and underlying myocardium.

            As for cardiac catheterization, this is now rarely performed. The indications for cardiac catheterization are for hemodynamic assessment of left ventricular function, measurement of pulmonary artery pressure and pulmonary vascular resistance, and for coronary angiography in older patients. On the other hand, cardiac magnetic resonance imaging (MRI) has become routine and provides the most objective quantitative measurement of right atrial and right ventricular size and function [11]. Our policy is to perform MRI in all patients beyond the neonatal period to evaluate adequacy of right ventricular function prior to surgical therapy.

            Other exams include the chest X-ray which still remains an important initial imaging study. In symptomatic neonates, massive cardiomegaly (wall-to-wall heart) can be seen; and beyond the neonatal period, there will be varying degrees of cardiac enlargement and the heart is usually described as globe shaped with a narrow waist. An enlarged right atrial silhouette is also usually seen and the lung fields may show normal of decreased vascularity due to hypoplasia. Typical electrocardiography (ECG) findings are the following: (a) prolonged PR interval, (b) tall P waves and (c) right bundle branch block. First degree AV block is another frequent finding. Atrial fibrillation or flutter is common in older patients and accessory conduction pathways are less common overall but typically will be found earlier on [5, 6].

            Management

            The surgical management of Ebstein anomaly is principally dependent on the severity at presentation. It is basically a dichotomous approach where either the patient presents with right sided heart failure at birth that cannot be medically managed and will be considered for conversion to single ventricle physiology; or the patient presents beyond the neonatal period with varying degrees of tricuspid regurgitation and right sided dysfunction and will be amenable to TV repair and right ventricular reconstruction. In select patients, biventricular repair in the neonatal period may be performed [11]. Also, in patients with borderline right ventricular function, the addition of a bidirectional Glenn shunt to a TV repair off loads the right ventricle by permitting direct passive passage of blood to the pulmonary circulation (1.5 ventricle repair). For patients who present in adulthood with late severe right or biventricular dysfunction, heart transplantation is the remaining option.

            In the neonate, evaluation begins ideally in the prenatal period. Prenatal diagnosis can be made by fetal echocardiography typically at 18–20 weeks of gestation. Generally, most fetuses tolerate pregnancy well, however rarely fetal hydrops can develop. Of great concern during the neonatal period is extreme cardiomegaly causing impaired pulmonary development. Another important factor is the presence of anatomic or functional obstruction of the right ventricular outflow tract. After delivery, assessment of degree of right ventricular failure and cyanosis is done; and if medical therapy can optimize the neonate. If medical management is unsuccessful, and typically these are neonates who are profoundly cyanotic, with a Great Ormond Street Score 3 or 4, cardiothoracic ratio >80% and severe TR [12] with a dysfunctional RV, functional pulmonary atresia with left ventricular due to massive right ventricular dilatation; RV exclusion with fenesterated patch closure of the TV orifice, atrial septectomy, right atrial reduction and right modified Blalock-Taussig shunt is performed [13]. Additionally, main pulmonary artery ligation is performed if there is severe pulmonary regurgitation. This procedure, also called the Starnes procedure, essentially abandons the right ventricle and converts to a single ventricle physiology. Mortality with this operation can be high but they are merely reflective of the severity of the ongoing disease process.

            For patients who survive or are diagnosed beyond the neonatal period, this subset is inherently of a less critical nature and will have varying degrees of TV regurgitation and right ventricular dysfunction. In the majority of these patients, they will ultimately require surgical intervention; however, timing of surgery depends on multiple factors. In our practice, we recommend surgery when symptoms of cyanosis, fatigue, exercise intolerance, progressive right ventricular dilatation and/or worsening tricuspid regurgitation are present. We also offer surgery to asymptomatic or mildly symptomatic patients with adequate right ventricular function and severe tricuspid regurgitation where preoperative imaging studies predict a high probability for successful repair. With this strategy, the aim is to both improve right ventricular function and TV competence, and also to optimize preservation of right ventricular function and prevent early heart failure.

            Popular techniques used in the past for tricuspid valve repair include the Mayo Clinic (Danielson) method [14] (Figure 3) and the Carpentier method [7, 15]. Both surgical techniques utilized a monocusp concept and selective RV plication. Current or contemporary concepts, while also involving selective RV plication, now focus not just on tricuspid leaflet reconstruction, but the restoration of a more anatomic right ventricle. This contemporary concept of tricuspid repair, the Cone reconstruction, was conceptualized by da Silva et al. [16] (Figure 4). This technique involves detachment and delamination of anterior, septal and posterior leaflet tissue, rotation and reattachment of the recruited leaflet tissue at the true atrioventricular junction/tricuspid valve annulus thereby creating a 360 degree leaflet “cone,” plication of the tricuspid annulus to reduce its size, and internal plication of the “atrialized” ventricle. If the anterior leaflet subvalvar apparatus is rudimentary and not well-formed, additional fenestrations are made on the anterior leaflet. In patients with borderline right ventricular function, a small atrial septal defect (5 mm) is created to allow “pop-of” into the left ventricle when there is worsening of RV function during the postoperative period. In older patients, a tricuspid annuloplasty ring is used to stabilize the repair. The Cone reconstruction may not be appropriate in patients older than 55–60 years with moderate pulmonary hypertension, significant left ventricular dysfunction (LVEF <30%), absent septal leaflet, a rudimentary or poorly developed anterior leaflet and severe RV dysfunction or enlargement. In these patients, successful rehabilitation of the right ventricle is unlikely and othotopic heart transplantation is a viable alternative. Furthermore, when tricuspid valve repair cannot be performed in the presence of adequate right ventricular function, tricuspid valve replacement with a porcine valve continues to be an excellent option [17].

            Figure 3:

            The Danielson Technique for Tricuspid Valve Repair in Ebstein Anomaly.

            The anterior leaflet functions as a monocuspid valve. (Reproduced with permission from [14] Copyright © 2003 Elsevier Inc).

            Figure 4:

            The Cone Reconstruction for Ebstein Anomaly.

            Tricuspid valve reconstruction with detachment and delamination of anterior, septal and posterior leaflet tissue, rotation and reattachment of the recruited leaflet tissue at the true atrioventricular junction/tricuspid valve annulus thereby creating a 360 degree leaflet “cone,” plication of the tricuspid annulus to reduce its size, and internal plication of “atrialized” ventricle. (Reproduced with permission from [16] Copyright © 2007 The American Association for Thoracic Surgery).

            Adjunctive procedures may also be performed in addition to tricuspid valve repair and right ventricular reconstruction. Selective use of the 1.5 ventricle repair through creation of a bidirectional cavopulmonary shunt (Glenn shunt) in patients with significant RV enlargement or dysfunction and/or moderate tricuspid valve stenosis (mean gradient greater than 8 mmHg) decreases the volume entering the right ventricle by 35–45%. This provides substantial unloading to the right ventricle and reduces stress on the tricuspid valve repair and improved loading of the left ventricle [18, 19]. This may not be appropriate in patients with severe left ventricular dysfunction where it cannot be determined if the dysfunction is secondary to the right ventricular compression. The pulmonary pressures, pulmonary vascular resistance and left atrial pressures should be documented to be low prior to proceeding with cavopulmonary shunt.

            Lastly, arrhythmia management is an important component of treating Ebstein anomaly. Routine preoperative electrophysiologic studies should be performed, and ablation of all accessory conduction pathways should be done at the electrophysiology lab prior to surgical repair. Surgical ablation of supraventricular tachyarrythmias has also been described and may be performed at the time of tricuspid valve repair [5, 20]. Specific arrhythmia procedures at the time of surgery are the use of cryoablation and radiofrequency ablation to perform a modified right sided maze and cavotricuspid isthmus ablation. This is done for paroxysmal atrial fibrillation or flutter. For chronic atrial fibrillation, a left atrial maze or pulmonary vein isolation is done [5, 6]. Rarely, patients who develop complete heart block will need a permanent pacemaker. We prefer epicardial leads with left ventricular pacing because of better reliability of pacing the left over the right ventricle in Ebstein anomaly.

            Results

            Advances both in operative techniques and post-operative management have contributed greatly to improved outcomes for patients with Ebstein anomaly. One of the largest experiences to date at the Mayo Clinic reported outcomes in 539 patients where they demonstrated excellent 10 and 20-year long term survival of 84.7 and 71.2%, respectively, and freedom from late reoperation at 10 and 20 years of 74.1 and 46.1%, respectively. Majority of patients (83%) remained in NYHA functional class I or II at late follow up [4].

            The Cone reconstruction has by far been the contemporary tricuspid valve repair of choice for Ebstein anomaly. Its more “anatomic” reconstruction has drawn much favor due to the perceived benefits of restoring the tricuspid valve to its native annulus and having more available right ventricular myocardium which may help improve its function. The early-to-intermediate results have been promising with outcomes at 4 years follow up showing significant improvement in TV regurgitation and NYHA Functional Class with low in-hospital mortality (2.5%) [16].

            Conclusion

            Ebstein anomaly is a very rare form of congenital heart disease. It can present in every age group and its clinical severity strongly correlates with the age of presentation. Patients requiring neonatal surgery indicate severe disease and high operative mortality, while patients presenting after the neonatal period have low operative mortality and will have excellent quality of life despite a higher frequency of repeat interventions. In infants up to adults, we recommend surgery for nearly all patients with at least moderate tricuspid regurgitation and varying degrees of right ventricular dysfunction with the goal of preserving long-term right ventricular function. Adjunctive procedures such as the bidirectional cavopulmonary anastomosis and ablations for arrhythmia are performed after careful evaluation of their indications. The continued challenge however is in neonates with poorly functioning ventricles, younger patients with recurrent TR and progressively worsening right ventricular function, and late presenting patients with severe biventricular function. In these patients, the most important goal is to preserve ventricular function as long as possible as there may be no recourse but to await transplantation.

            Disclosure Statement

            All of the authors including Eric Jeng, Karl Reyes, Susan Cooke, David Hall, and Mark Bleiweis are in agreement with the content in the manuscript. There are no sources of financial support in the form of grants, equipment, and/or pharmaceutical items for this research.

            Conflict of Interest

            The authors declare that they have no conflicts of interest.

            References

            1. CohenLS, FriedmanJM, JeffersonEM, WeinerML. A reevaluation of risk of in utero exposure to lithium. J Am Med Assoc 1994;271:14650.

            2. EdwardsWD. Embryology and pathologic features of Ebstein’s anomaly. Prog Pediatr Cardiol 1993;2:515.

            3. DearaniJA, DanielsonGK. Ebstein’s anomaly of the tricuspid valve. In: Mavroudis C, Backer CL, editors. Pediatric cardiac surgery. 3rd ed. Philadelphia, PA: Mosby; 2003. pp. 52436.

            4. BrownMI, DearaniJA, DanielsonGK, CettaF, ConnollyHM, WarnesCA, et al. The outcomes of operations for 539 patients with Ebstein anomaly. J Thorac Cardiovasc Surg 2008;135(5):112036.

            5. KhositsethA, DanielsonGK, DearaniJA, MungerTM, PorterCJ. Superventricular arrhythmias in Ebstein anomaly: management and outcome. J Thorac Cardiovasc Surg 2004;128(6):82633.

            6. StulakJM, SharmaV, CannonBC, AmmashN, SchaffHV, DearaniJA. Optimal surgical ablation of atrial tachyarrhythmias during correction of Ebstein anomaly. Ann Thorac Surg 2015;99(5):17005; discussion 1705.

            7. CarpentierA, ChauvaudS, MaceL, ReillandJ, MihaileanuS, MarinoJP, et al. A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J Thorac Cardiovasc Surg 1988;96:92101.

            8. CelermajerDS, BullC, TillJA, CullenS, VassilikosVP, SullivanD, et al. Ebstein’s anomaly: presentation and outcome from fetus to adult. J Ann Coll Cardiol 1994;23:1706.

            9. Attenhofer JostCH, ConnollyHM, ScottCG, BurkhartHM, AmmashNM, DearaniJA. Increased risk of possible paradoxical emobolic events in adults with Ebstein anomaly and severe tricuspid regurgitation. Congenit Heart Dis 2014;9(1):307.

            10. RobersonDA, SilvermanNH. Ebstein’s anomaly: echocardiographic and clinical features in the fetus and neonate. J Am Coll Cardiol 1989;14:13007.

            11. Knott-CraigCJ. Management of neonatal Ebstein’s anomaly. Oper Tech Thorac Cardiovasc Surg 2004;9:194207.

            12. BostonUS, GoldbergSP, WardKE, OverholtED, SpentzasT, ChinTK, et al. Complete repair of Ebstein anomaly in neonates and young infants: a 16 year follow-up. J Thorac Cardiovasc Surg 2011;141:11639.

            13. StarnesVA, PirlickPT, BernsteinD, GriffinML, ChoyM, ShumwayNE. Ebstein anomaly appearing in the neonate. A new surgical approach. J Thorac Cardiovasc Surg 1991;101(6):10827.

            14. DearaniJA, DanielsonGK. Tricuspid valve repair for Ebstein’s anomaly. Oper Tech Thorac Cardiovasc Surg 2003;8:18892.

            15. ChauvaudS. Ebstein malformation. Surgical treatment and results. Thorac Cardiovasc Surg 2000;48(4):2203.

            16. Da SilvaP, BaumgrauzFJ, FonsecaL, FranchiSM, LopesLM, TavaresGM, et al. The cone reconstruction of the tricuspid valve in Ebstein anomaly. The operation: early and midterm results. J Thorac Cardiovasc Surg 2007;133(1):21523.

            17. BrownML, DearaniJA, DanielsonGK, CettaF, ConnollyHM, WarnesCA, et al. Comparison of the outcome of porcine bioprosthetic versus mechanical prosthetic replacement of the tricuspid valve in Ebstein anomaly. Am J Cardiol 2009;103(4):55561.

            18. RajuV, DearaniJA, BurkhartHM, GroganM, PhillipsSD, AmmashN, et al. Right ventricular unloading for heart failure related to Ebstein malformation. Ann Thorac Surg 2014;98(1):167–73; discussion 173–4.

            19. MalhotraSP, PetrossianE, ReddyVM, QiuM, MaedaK, SulemanS, et al. Selective right ventricular unloading and novel technical concepts in Ebstein anomaly. Ann Thorac Surg 2009;88(6):197581; discussion 1981.

            20. GreasonKL, DearaniJA, TheodoroDA, PorterCB, WarnesCA, DanielsonGK. Surgical management of atrial tachyarrythmias associated with congenital cardiac anomalies: Mayo Clinic experience. Semin Thorac Cardiovas Surg Pediatr Card Surg Annu 2004;6:5971.

            Author and article information

            Journal
            CVIA
            Cardiovascular Innovations and Applications
            CVIA
            Compuscript (Ireland )
            2009-8782
            2009-8618
            May 2018
            May 2018
            : 3
            : 1
            : 13-20
            Affiliations
            [1] 1University of Florida, Congenital Heart Center, Congenital Heart Surgery, 1600 Southwest Archer Road, Gainesville, FL 32608, USA
            [2] 2University of Florida, Department of Surgery, Division of Thoracic and Cardiovascular Surgery, 1600 Southwest Archer Road, Gainesville, FL 32608, USA
            [a] aBoth authors equally contributed to this work.
            Author notes
            Correspondence: Karl M. Reyes, MD, Associate Professor, Congenital Heart Center, Departments of Surgery and Pediatrics, Congenital Heart Surgery, University of Florida – Shands Children’s Hospital, 1600 Archer Road – HD 308, Gainesville, FL 32608, USA, Tel.: +(352) 273-9569, Fax: +(352) 273-5927, E-mail: karl.reyes@ 123456peds.ufl.edu
            Article
            cvia20170052
            10.15212/CVIA.2017.0052
            0fa39311-2025-4550-af2b-780a096f5901
            Copyright © 2018 Cardiovascular Innovations and Applications

            This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 Unported License (CC BY-NC 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc/4.0/.

            History
            : 14 October 2017
            : 12 March 2018
            : 3 April 2018
            Categories
            Reviews

            General medicine,Medicine,Geriatric medicine,Transplantation,Cardiovascular Medicine,Anesthesiology & Pain management
            tricuspid valve malformation,surgical management,right ventricle malformation,Ebstein anomaly,Ebstein,congenital

            Comments

            Comment on this article